BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 32734361)

  • 1. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
    J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microparticles Expressing Myeloperoxidase and Complement C3a and C5a as Markers of Renal Involvement in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Antovic A; Mobarrez F; Manojlovic M; Soutari N; De Porta Baggemar V; Nordin A; Bruchfeld A; Vojinovic J; Gunnarsson I
    J Rheumatol; 2020 May; 47(5):714-721. PubMed ID: 31371653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis].
    Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of high mobility group box 1 on Toll-like receptor 9 in B cells in myeloperoxidase-ANCA-associated vasculitis.
    Wang C; Deng H; Gong Y; You R; Chen M; Zhao MH
    Autoimmunity; 2020 Feb; 53(1):28-34. PubMed ID: 31790283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
    Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
    [No Abstract]   [Full Text] [Related]  

  • 6. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
    Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
    Berglin E; Mohammad AJ; Dahlqvist J; Johansson L; Eriksson C; Sjöwall J; Rantapää-Dahlqvist S
    J Autoimmun; 2021 Feb; 117():102579. PubMed ID: 33340843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
    Simon A; Subra JF; Guilpain P; Jeannin P; Pignon P; Blanchard S; Garo E; Jaillon S; Chevailler A; Renier G; Puéchal X; Bottazzi B; Mantovani A; Delneste Y; Augusto JF
    PLoS One; 2016; 11(1):e0147091. PubMed ID: 26797217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.
    Maruyama H; Hirayama K; Nagai M; Ebihara I; Shimohata H; Kobayashi M
    Clin Rheumatol; 2016 Oct; 35(10):2469-76. PubMed ID: 27251675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mobility group box-1 contributes to anti-myeloperoxidase antibody-induced glomerular endothelial cell injury through a moesin-dependent route.
    Deng H; Wang C; Chang DY; Hu N; Chen M; Zhao MH
    Arthritis Res Ther; 2017 Jun; 19(1):125. PubMed ID: 28587670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA.
    Gong Y; Shen C; Meng T; Lin W; Hu X; Tang R; Xiong Q; Ooi JD; Eggenhuizen PJ; Chen J; Zhou YO; Luo H; Xu J; Liu N; Xiao P; Xiao X; Zhong Y
    Clin Exp Med; 2024 Apr; 24(1):66. PubMed ID: 38564029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
    Hirose O; Itabashi M; Takei T; Nitta K
    Mod Rheumatol; 2015 Mar; 25(2):230-4. PubMed ID: 25388618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of anti-HMGB1 antibody and anti-moesin antibody in ANCA-associated vasculitis.
    Wang Y; Shi J; Tan C; Zou L; Chen P; Luo P
    Med Clin (Barc); 2023 Aug; 161(3):101-106. PubMed ID: 37211482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma FXII is associated with disease activity in ANCA-associated vasculitis: A Retrospective Cross-Sectional Study in Western China.
    Chen SS; Luo HJ; Li H; Zhang H; Li YY; Li Y; Wang W; Ding HL
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111067. PubMed ID: 37866310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease.
    Kambas K; Chrysanthopoulou A; Vassilopoulos D; Apostolidou E; Skendros P; Girod A; Arelaki S; Froudarakis M; Nakopoulou L; Giatromanolaki A; Sidiropoulos P; Koffa M; Boumpas DT; Ritis K; Mitroulis I
    Ann Rheum Dis; 2014 Oct; 73(10):1854-63. PubMed ID: 23873874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
    Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
    Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis.
    Jonasdottir AD; Antovic A; Qureshi AR; Nordin A; Malmström V; Gunnarsson I; Bruchfeld A
    Scand J Rheumatol; 2023 May; 52(3):293-301. PubMed ID: 35383519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.